Evidence map›Paper›PMID 39945280›Full record

ArticleTissue barriers2025

β-arrestin 1 and integrin-linked kinase interact in epidermal keratinocytes and regulate cell motility.

Hannah Murphy-Marshman, Iordanka A Ivanova, Moshmi Bhattacharya, Lina Dagnino

Abstract read
In one paragraph

Article in Tissue barriers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah Murphy-MarshmanDepartment of Physiology and Pharmacology, Children's Health Research Institute and Lawson Health Research Institute, London, Ontario, Canada.ORCID 0000-0002-3885-2992
Iordanka A IvanovaDepartment of Physiology and Pharmacology, Children's Health Research Institute and Lawson Health Research Institute, London, Ontario, Canada.ORCID 0000-0003-4988-3820
Moshmi BhattacharyaDepartment of Oncology, University of Western Ontario, London, ON, Canada.ORCID 0000-0002-9191-9877
Lina DagninoDepartment of Physiology and Pharmacology, Children's Health Research Institute and Lawson Health Research Institute, London, Ontario, Canada.ORCID 0000-0003-1483-5159

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arrestins and integrin-linked kinase (ILK) are important scaffold proteins that regulate myriad cell functions in metazoans. β-arrestins, first identified as critical components in G-protein-coupled receptor (GPCR) signaling pathways, participate in inflammatory, immunomodulatory and tissue repair processes in GPCR-dependent and -independent manners. ILK is a central mediator of signaling cascades elicited by activation of integrins, regulating cell motility, proliferation, and mechanotransduction. In the epidermis, ILK is essential for maintenance of barrier function, hair follicle development, melanocyte colonization and regeneration after injury. In this tissue, β-arrestin 2 mitigates inflammatory processes and development of allergic dermatitis, which also is associated with loss of epidermal barrier function. However, the functional role of β-arrestin 1 in epidermal cells is poorly understood. We now report that β-arrestin 1 directly binds ILK, forming hitherto unidentified protein complexes in epidermal keratinocytes. In the absence of exogenous GPCR ligand stimulation, β-arrestin 1 and ILK are found throughout the cytoplasm in epidermal keratinocytes, and also co-localize to plasma membrane regions associated with cell protrusions. Inactivation of the genes that encode both β-arrestin 1 and 2 attenuates forward cell migration, whereas expression of ILK together with β-arrestin 1 restores cell motility. The cooperative effect of ILK and β-arrestin 1 in promoting directional cell migration may have important implications for epidermal regeneration and reestablishment of barrier function after injury.

Indexed as

beta-Arrestin 1Cell MovementEpidermisKeratinocytesProtein Serine-Threonine KinasesAnimalsHumansMiceScaffold Protein ILKbeta-Arrestin 1Protein Serine-Threonine KinasesScaffold Protein ILKArrestinsdirectional migrationepidermisILKkeratinocytesscaffold proteinsβ-arrestin

Identifiers

PMID39945280
PMCPMC12667664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.